What are the recommended fluconazole dosing regimens for oral or intravenous administration in adults and children for different infections and in renal impairment?

Fluconazole Dosing Recommendations

Fluconazole dosing varies significantly by infection type, patient age, and renal function, with most adult infections requiring 200-400 mg daily (3-6 mg/kg), while severe infections and candidemia require loading doses of 800 mg followed by 400 mg daily. 1

Adult Dosing by Indication

Oropharyngeal Candidiasis

• Mild disease: Topical agents preferred (clotrimazole troches 10 mg 5 times daily) 1
• Moderate to severe disease: Fluconazole 100-200 mg daily for 7-14 days 1
• Refractory disease: Increase to itraconazole solution 200 mg daily or posaconazole 1
• Chronic suppression (if needed): 100 mg three times weekly 1

Esophageal Candidiasis

• Oral therapy: 200-400 mg (3-6 mg/kg) daily for 14-21 days 1
• IV therapy (if oral not tolerated): 400 mg (6 mg/kg) daily 1
• Treatment duration: minimum 3 weeks and at least 2 weeks after symptom resolution 2

Candidemia and Invasive Candidiasis

• Loading dose: 800 mg (12 mg/kg) on day 1 1
• Maintenance: 400 mg (6 mg/kg) daily 1
• Duration: 2 weeks after blood culture clearance and symptom resolution 1
• Critical caveat: This applies only to fluconazole-susceptible organisms; echinocandins are preferred for empiric therapy in ICU patients 1

Urinary Tract Infections

• Cystitis/UTI: 200-400 mg (3-6 mg/kg) daily for 2 weeks 1
• Doses as low as 50-200 mg daily have been used 2

Cryptococcal Meningitis

• Acute treatment: 400 mg on day 1, then 200-400 mg daily 2
• Duration: 10-12 weeks after CSF culture negativity 2
• Suppressive therapy (AIDS patients): 200 mg daily indefinitely 2

Vaginal Candidiasis

• Single dose: 150 mg orally once 2

Prophylaxis (Bone Marrow Transplant)

• 400 mg daily starting several days before anticipated neutropenia, continuing 7 days after neutrophil count >1000 cells/mm³ 2

Pediatric Dosing

General Equivalency

The following provides equivalent exposure between pediatric and adult patients 2:

• 3 mg/kg pediatric = 100 mg adult
• 6 mg/kg pediatric = 200 mg adult
• 12 mg/kg pediatric = 400 mg adult
• Maximum: 600 mg/day 2

Specific Pediatric Indications

Oropharyngeal candidiasis: 6 mg/kg day 1, then 3 mg/kg daily for ≥2 weeks 2

Esophageal candidiasis: 6 mg/kg day 1, then 3 mg/kg daily (up to 12 mg/kg based on response) for ≥3 weeks 2

Systemic Candida infections (≥3 months old): 25 mg/kg loading dose (max 800 mg), then 12 mg/kg daily (max 400 mg) 3

Cryptococcal meningitis: 12 mg/kg day 1, then 6-12 mg/kg daily for 10-12 weeks after CSF negativity 2, 3

Neonatal Dosing (Critical Age-Based Adjustments)

Premature neonates (26-29 weeks gestational age):

• First 2 weeks of life: Same mg/kg dose as older children but every 72 hours 2
• After 2 weeks: Dose once daily 2

Term neonates and infants <3 months:

• Gestational age ≥30 weeks: 25 mg/kg day 1, then 12 mg/kg daily 3
• Gestational age <30 weeks: 25 mg/kg day 1, then 9 mg/kg daily 3

The rationale for these adjustments is the prolonged elimination half-life in premature infants due to immature renal function 4.

Renal Impairment Dosing

Critical principle: Fluconazole is primarily renally eliminated as unchanged drug, requiring dose adjustment in renal dysfunction 2, 5.

Dosing Algorithm for Renal Impairment

1. Give full loading dose (50-400 mg based on indication) regardless of renal function 2

2. Adjust maintenance dose based on creatinine clearance (CrCl):

   • CrCl >50 mL/min: 100% of normal dose 2
   • CrCl ≤50 mL/min (no dialysis): 50% of normal dose 2
   • Hemodialysis: 100% of recommended dose after each dialysis session; on non-dialysis days, give 50% dose 2

Estimating Creatinine Clearance

Adults:

• Males: [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)] 2
• Females: 0.85 × male value 2

Children: [K × height (cm)] / serum creatinine (mg/dL)

• K = 0.55 for children >1 year
• K = 0.45 for infants 2

Special Renal Replacement Scenarios

Continuous veno-venous hemodialysis (CVVHD): Recent evidence demonstrates that standard dosing is insufficient. At least 400 mg twice daily is required to achieve therapeutic targets in critically ill patients on CVVHD 6. This represents a significant departure from older recommendations and reflects the substantial drug removal by modern high-flux dialysis.

ECMO patients (≥3 months old): 35 mg/kg loading dose (max 800 mg), then 12 mg/kg daily (max 400 mg) 3

Peritoneal dialysis: Fluconazole clearance is reduced but variable; individualized dosing based on therapeutic drug monitoring is recommended 7.

Important Clinical Caveats

Therapeutic Drug Monitoring

Target plasma concentrations: 4-20 mcg/mL 4. Consider monitoring in:

• Neonates and very low birth weight infants
• Patients with fluctuating renal function
• Those on CRRT with variable dialysis parameters 8

Loading Dose Rationale

A loading dose of twice the maintenance dose on day 1 achieves near-steady-state concentrations by day 2, which is critical given fluconazole's long half-life (22-32 hours in normal renal function) 2, 9. Without loading, therapeutic levels may not be reached for 5-7 days.

Recent Evidence on eGFR-Based Dosing

A 2026 population pharmacokinetic study suggests that eGFR-based dosing with a loading dose of 2.8 times the maintenance dose may optimize target attainment better than standard regimens 10. However, this requires prospective validation before routine implementation.

Administration

• Oral and IV doses are equivalent due to >90% oral bioavailability 2
• IV infusion rate: maximum 200 mg/hour 3
• Can be taken with or without food 2

Drug Interactions

Fluconazole inhibits CYP2C9 and CYP3A4. Monitor closely when co-administered with warfarin, phenytoin, cyclosporine, oral hypoglycemics, and other CYP substrates 9. Rifampin decreases fluconazole levels 9.